Palvella Therapeutics, Inc. (PVLA) Operating margin 2016–2023
Palvella Therapeutics, Inc. (PVLA) operating margin by fiscal year — reported operating income divided by reported revenue.
-27.7%FY2023 · since FY2016: -390.3% → -27.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -27.7% | +140.1 pp |
| FY2022 | -167.8% | -2.9 pp |
| FY2021 | -165.0% | -49.3 pp |
| FY2020 | -115.7% | -53.5 pp |
| FY2019 | -62.2% | +50.9 pp |
| FY2018 | -113.1% | -55.4 pp |
| FY2017 | -57.7% | +332.6 pp |
| FY2016 | -390.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice